Elsevier

The Lancet

Volume 315, Issue 8167, 8 March 1980, Pages 509-512
The Lancet

RETURN OF FERTILITY AFTER DISCONTINUATION OF DEPOT MEDROXYPROGESTERONE ACETATE AND INTRA-UTERINE DEVICES IN NORTHERN THAILAND

https://doi.org/10.1016/S0140-6736(80)92765-8Get rights and content

Abstract

796 Thai women who stopped using the long-acting injectable contraceptive 'Depo-Provera' (medroxyprogesterone acetate) and 125 women who had an intra-uterine device removed to have a planned pregnancy were followed-up to ascertain the delay between conception and the end of contraception, and to determine the proportion of women who did not conceive in the 2 years after discontinuation. The median delay before conception was 5·5 months plus the estimated duration of the effect of the last injection of depo-provera and 4·5 months after discontinuing the IUD. Since depo-provera acts for approximately 15 weeks, women can expect a median delay to conception of around 9 months after their last injection. The proportions of women who did not conceive within 1 year and within 2 years of stopping contraception by the two methods were similar. There was no evidence to suggest that prolonged use of depo-provera increases the delay before conception, and the return of fertility among never pregnant ex-users resembled that of ever pregnant ex-users.

References (11)

There are more references available in the full text version of this article.

Cited by (56)

  • Intrauterine device use, sexually transmitted infections, and fertility: a prospective cohort study

    2021, American Journal of Obstetrics and Gynecology
    Citation Excerpt :

    The FACT Study participants met the following inclusion criteria: (1) ages 18 to 35 years, (2) desiring conception, (3) sexually active with a male partner, (4) ability to consent in English or Spanish, and (5) willing to comply with all study procedures and follow-up. We excluded patients with a positive pregnancy test at baseline, if they had a history of infertility or were surgically sterile, and if they used DMPA in the past 5 months, as DMPA can be associated with a longer return to fertility.8 Before enrollment, we obtained institutional review board approval, and all participants completed the informed consent process.

  • Progestin-only contraception: Injectables and implants

    2014, Best Practice and Research: Clinical Obstetrics and Gynaecology
    Citation Excerpt :

    WHO advises that repeat injections can be given 2 weeks early or up to 2 weeks late for NET-EN and 2 weeks early or up to 4 weeks late for DMPA [25,30]. Return to fertility after a DMPA-IM injection averages between 9 and 10 months (i.e. 6–7 months longer than the expected duration of effect; one study reported a range of 4–31 months) [31,32]. This may be slightly shorter with NET-EN [33].

  • Gestational trophoblastic disease

    2012, Best Practice and Research: Clinical Obstetrics and Gynaecology
    Citation Excerpt :

    Longer time may be needed for return of fertility after the use of depot medroxyprogesterone (DMPA), which takes about 4–5 months for the return of ovulation and about 5–7 months for conception, although the ovulation suppression may rarely persist for as long as 18 months after the last injection.84,96 A Thai study,97 which included 796 women using DMPA, showed a median delay of 5.5 months before conception. As the effect of DMPA can last for 15 weeks, a median delay to conception of around 9 months after the last injection can be anticipated.

  • Return to fertility following discontinuation of oral contraceptives

    2009, Fertility and Sterility
    Citation Excerpt :

    Of the progestin-only contraceptives, only the progestin-only pill has been shown to have conception rates comparable to that of combined OCs or nonhormonal family planning methods. Specifically, the 12-month conception rate in women discontinuing progestin-only pills in order to conceive is 95% (1), compared with 70%–78% in women discontinuing depot medroxyprogestrone acetate (DMPA) injections (26, 27) and 77%–81% in women discontinuing Norplant (levonorgestrel implants: Wyeth, Collegeville, PA) (27, 48). As noted, the rates seen with progestin-only pills are comparable to 12-month conception rates in women wishing to conceive after discontinuing the use of condoms (91%) (1), or natural family planning by timing of intercourse (n = 342), showing that 92% had conceived by 12 months (49).

View all citing articles on Scopus
1

Present address: Department of Medical Statistics and Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street (Gower Street), London WC1E 7HT.

View full text